{"id":"W4207010819","doi":"10.1016/j.jtct.2022.01.017","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration; U.S. Food and Drug Administration; Astellas Pharma; Daiichi-Sankyo; Bayer Fund; Kiadis Pharma; TG Therapeutics; Medical College of Wisconsin; Chimerix; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; AbbVie; Merck; Spectrum Pharmaceuticals; National Cancer Institute; Gilead Sciences; Karyopharm Therapeutics; Novartis; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Falk Foundation; CareDx; Amyloidosis Foundation; Pfizer; Alexion Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Internal medicine; Hazard ratio; Transplantation; Prolymphocytic leukemia; Regimen; Cumulative incidence; Gastroenterology; Hematopoietic stem cell transplantation; Alemtuzumab; Oncology; Confidence interval; Leukemia; Surgery; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834758,0.0001942072,0.0004289884,0.0003771468,0.0001820594,0.00002968498,0.0002156027,0.00008936111,0.0001505469],"category_scores_gemma":[0.000008038463,0.0001489228,0.0001670427,0.0004213072,0.0001615795,0.00007517288,0.00001547316,0.0002993914,0.000001136208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005611634,"about_ca_system_score_gemma":0.0009958134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001193249,"about_ca_topic_score_gemma":0.0001245304,"domain_scores_codex":[0.9976586,0.000356496,0.0005227872,0.0004383502,0.0007309223,0.0002928587],"domain_scores_gemma":[0.9987274,0.0006964366,0.0001028422,0.0002399094,0.0001392334,0.00009420927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02158687,0.001937815,0.610819,0.00200532,0.002643005,0.0008312797,0.06165198,0.0007167724,0.2959194,0.0002247436,0.000109991,0.001553866],"study_design_scores_gemma":[0.2305313,0.002136773,0.1540493,0.0002773167,0.00275497,0.0003116893,0.007414564,0.01457335,0.5847722,0.0006292784,0.001654848,0.0008944661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928296,0.003362553,0.0008915676,0.0004005854,0.00008163867,0.001349825,0.0007536062,0.00001654079,0.0003141063],"genre_scores_gemma":[0.9911838,0.006245491,0.0001503349,0.0002298844,0.0000339482,0.0003098931,0.001630199,0.00002886447,0.0001876247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4567697,"threshold_uncertainty_score":0.6072897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0394564369277786,"score_gpt":0.3046050989104168,"score_spread":0.2651486619826382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}